Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach
- PMID: 20871221
- DOI: 10.1097/PAS.0b013e3181f0a873
Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach
Abstract
Objective: To investigate the different nature between hepatoid adenocarcinoma of the stomach (HAS) and common stomach cancer without the hepatoid differentiation areas (non-HAS).
Methods: From January 1996 to December 2007, 45 patients were diagnosed as HAS on the basis of the characteristic histologic features resembling hepatocellular carcinoma in Fudan University Shanghai Cancer Center. The clinicopathologic features and the relevant prognosis of these patients were evaluated. In addition, 225 stage-matched common stomach cancer patients were selected as controls.
Results: Histologically, the polygonal tumor cells were arranged in trabecular fashion or solid nests separated by narrow fibrous stroma composed of sinusoid-like capillaries. Immunohistochemically, the tumor cells were positive for α-fetoprotein. Under transmission electron microscope, numerous circular granules of dense electron were found in the cytoplasm. HAS showed a higher rate of vascular invasion, lymph node metastasis, and liver metastasis than non-HAS. The 5-years survival rates of HAS and non-HAS were 9% and 44%, respectively. The prognosis of HAS was poorer than that of non-HAS (P<0.05).
Conclusion: HAS had different clinicopathologic features and prognosis from non-HAS.
Similar articles
-
An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.J Surg Oncol. 2012 Sep 1;106(3):299-303. doi: 10.1002/jso.23073. Epub 2012 Mar 2. J Surg Oncol. 2012. PMID: 22389029
-
Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.J Dig Dis. 2007 Feb;8(1):23-8. doi: 10.1111/j.1443-9573.2007.00279.x. J Dig Dis. 2007. PMID: 17261131
-
Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94. Hepatogastroenterology. 1997. PMID: 9356878
-
Multivariate prognostic study on large gastric cancer.J Surg Oncol. 2007 Jul 1;96(1):14-8. doi: 10.1002/jso.20631. J Surg Oncol. 2007. PMID: 17582596 Review.
-
Clinicopathological features of hepatoid adenocarcinoma and non-hepatoid adenocarcinoma of the stomach: A systematic review and meta-analysis.Cancer Med. 2024 Aug;13(16):e70130. doi: 10.1002/cam4.70130. Cancer Med. 2024. PMID: 39186327 Free PMC article.
Cited by
-
Gastric hepatoid adenocarcinoma: a computed tomography report of six cases.World J Gastroenterol. 2014 Oct 28;20(40):15001-6. doi: 10.3748/wjg.v20.i40.15001. World J Gastroenterol. 2014. PMID: 25356063 Free PMC article.
-
The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.Bosn J Basic Med Sci. 2017 May 20;17(2):138-143. doi: 10.17305/bjbms.2017.1684. Bosn J Basic Med Sci. 2017. PMID: 28273032 Free PMC article.
-
Hepatoid adenocarcinoma of the stomach: A case report of a rare type of gastric cancer.Oncol Lett. 2016 Feb;11(2):1077-1080. doi: 10.3892/ol.2015.4023. Epub 2015 Dec 10. Oncol Lett. 2016. PMID: 26893695 Free PMC article.
-
Gastric Adenocarcinoma with Enteroblastic Differentiation Resected through Endoscopic Submucosal Dissection: A Case Report.Case Rep Gastroenterol. 2024 Feb 8;18(1):68-73. doi: 10.1159/000535954. eCollection 2024 Jan-Dec. Case Rep Gastroenterol. 2024. PMID: 38333765 Free PMC article.
-
Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.Curr Med Sci. 2018 Dec;38(6):1054-1061. doi: 10.1007/s11596-018-1983-1. Epub 2018 Dec 7. Curr Med Sci. 2018. PMID: 30536069
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical